Robotic catheter repair for leaky tricuspid heart valve
Part of Heart & circulation clinical trials.
This trial tests a new robotic catheter procedure to repair a leaky tricuspid valve (the valve on the right side of your heart). Instead of open-heart surgery, doctors thread a tiny device through a vein in your neck to fix the valve. It may be an option if you have severe leaking and your heart team thinks surgery is too risky for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–90 years old
- Severe tricuspid valve leaking (regurgitation) that causes symptoms like shortness of breath or swelling
- Your heart team (cardiologists, surgeons, anesthetists) agrees you are too high-risk for traditional open-heart valve surgery
- Your heart anatomy is suitable for this catheter-based procedure, confirmed by imaging
- You have not had prior tricuspid valve surgery or repair that would interfere with this new device
- Your heart's pumping strength (left ventricle ejection fraction) is 40% or higher
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new catheter-based device to repair a leaky tricuspid heart valve (tricuspid regurgitation) in people who still have symptoms like shortness of breath or swelling despite taking heart medications. The goal is to see if the procedure is safe and can help reduce the leak.
This study tracks people with a leaking tricuspid valve and weakened heart pumping to see how a minimally invasive repair procedure affects their health over time. It aims to improve treatment for those with heart failure.
This trial tests a new device called the Lux-Valve Plus to replace the tricuspid valve without open-heart surgery. It may help people who have severe leaking of the tricuspid valve and are too high-risk for surgery or not eligible for other non-surgical treatments.
This trial studies a catheter-based repair to help fix a leaky tricuspid valve (regurgitation), especially when you’re also having another heart surgery. It aims to improve valve function and symptoms while tracking safety and outcomes.
This trial tests a catheter-based procedure (done through the blood vessels) to repair a severely leaky tricuspid valve. It may help people with symptoms or past hospitalizations from tricuspid valve leakage who are higher-risk for standard surgery.
This trial tests a new catheter-based device to replace your tricuspid valve without open-heart surgery. It's for people with severe tricuspid regurgitation who are at high risk for surgery.
Hear when a new Transcatheter Valve Replacement trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.